Cargando…
Synthesis of Tetrabenazine and Its Derivatives, Pursuing Efficiency and Selectivity
Tetrabenazine is a US Food and Drug Administration (FDA)-approved drug that exhibits a dopamine depleting effect and is used for the treatment of chorea in Huntington’s disease. Mechanistically, tetrabenazine binds and inhibits vesicular monoamine transporter type 2, which is responsible for importi...
Autor principal: | Paek, Seung-Mann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179236/ https://www.ncbi.nlm.nih.gov/pubmed/32151010 http://dx.doi.org/10.3390/molecules25051175 |
Ejemplares similares
-
Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011) -
Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007) -
Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010) -
Enantioselective synthesis of (−)-tetrabenazine via continuous crystallization-induced diastereomer transformation
por: Kukor, Andrew J., et al.
Publicado: (2022) -
Structural Mechanisms for VMAT2 inhibition by tetrabenazine
por: Dalton, Michael P., et al.
Publicado: (2023)